Clinical significance of P-glycoprotein expression in breast cancer

Chinese Journal of Cancer Research

Volumn 11, Issue 3, 1999, Pages 218-220

  Li, E X ^a   Li, R ^a   Zhang, Z H ^a   Wang, J B ^a  

^a XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Immunohistochemistry; P glycoprotein; Prognosis

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUATION; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0032887812     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-999-0017-8     Document Type: Article

References (8)